保留Retzius间隙的机器人辅助根治性前列腺切除术在中叶突出患者中的优势#br# |
| |
引用本文: | 钱佳俊,张梦洁,邱雪峰,郭宏骞.保留Retzius间隙的机器人辅助根治性前列腺切除术在中叶突出患者中的优势#br#[J].中国肿瘤外科杂志,2021,13(4):335-339. |
| |
作者姓名: | 钱佳俊 张梦洁 邱雪峰 郭宏骞 |
| |
作者单位: | 1. 南京大学医学院附属鼓楼医院2. 南京市鼓楼医院 |
| |
摘 要: | 目的研究保留Retzius间隙的机器人辅助根治性前列腺切除术(RS-RARP)对显著中叶突出(PML)患者的疗效。方法收集2017年7月至2019年12月于南京大学附属鼓楼医院行传统机器人辅助根治性前列腺切除术(RARP)和RS-RARP的患者资料,并比较了两组患者的基本情况,围手术期结果以及短期肿瘤学和尿控结局。结果共78例患者入组,其中39例接受了传统的RARP,39例接受了RS-RARP。 RS-RARP组的操作时间较短(P<0.05)。两组患者的总切缘阳性率及基底部切缘阳性率差异无统计学意义(P>0.05)。在12个月的随访时间中,两组患者的生化复发率差异无统计学意义(P>0.05),尿失禁恢复率差异有统计学意义(P<0.05)。结论RS-RARP治疗显著PML患者,具有更短的操作时间及更好的尿控结果,值得临床推广应用。
|
收稿时间: | 2020-11-12 |
修稿时间: | 2021-03-26 |
The advantage of Retzius-sparing robot-assisted radical prostatectomy in patients with protruded median lobe |
| |
Abstract: | Objective: To investigate the effect of protruded median lobe (PML) among patients underwent Retzius-sparing robot-assisted radical prostatectomy (RS-RARP).
Methods: Patients who had undergone traditional RARP or RS-RARP in Affiliated Drum Tower hospital, Medical School of Nanjing University during July 2017 to December 2019 were collected. The basic information, perioperative outcomes, short-term oncological, and UC outcomes were compared among the two groups.
Results: 78 patients who had undergone RARP were included in our study. 39 patients underwent traditional RARP and the other underwent RS-RARP. The age, PSA and PV showed no obvious difference during two groups (P= 0.883, 0.586, 0.076). Perioperative characteristics including estimated blood loss, nerve sparing, complications and length of stay were not statistically different among the three groups (P= 0.943, 0.361, 0.209, 0.233, respectively). Console time of RS-RARP were shorter and statistically different(P= 0.036). The rate of positive surgical margin (PSM) and positive surgical margin at base (PSMB) were not significantly different in the two groups (P= 0.151, 0.395). Comparison between the two approaches showed better recovery of UC (HR = 1.885,95%CI:1.136-3.128,log-rank P= 0.002) and similar biochemical recurrence (log-rank P= 0.079) after RS-RARP.
Conclusion: Compared with the traditional approach, RS-RARP offers better UC outcome and shorter console time for patients with significant PML under the similar oncological outcome. |
| |
Keywords: | |
|
| 点击此处可从《中国肿瘤外科杂志》浏览原始摘要信息 |
| 点击此处可从《中国肿瘤外科杂志》下载免费的PDF全文 |
|